• Pregnenolone Carbonitrile: Advancing Translational Liver Res

  2026-05-26

  This thought-leadership article analyzes Pregnenolone Carbonitrile's unique mechanistic leverage as a rodent PXR agonist and antifibrotic tool, integrating new evidence from MASLD/MASH models, and offers strategic guidance for translational researchers. The piece contextualizes PCN against the competitive landscape, details protocol considerations, and forecasts emerging research frontiers, all while referencing recent peer-reviewed findings and APExBIO's product leadership.

• PEDV Exploits IMPDH-Dependent Guanine Biosynthesis for Repli

  2026-05-26

  This study reveals that porcine epidemic diarrhea virus (PEDV) relies on host IMPDH-dependent guanine nucleotide biosynthesis to support its replication. Both genetic and pharmacological inhibition of IMPDH, including with Merimepodib (VX-497), sharply reduced viral proliferation, positioning IMPDH as a promising host-directed antiviral target for PEDV.

• Sensitive Yeast Platform for mTOR Inhibitor Discovery and Va

  2026-05-26

  This study introduces a highly drug-sensitized yeast system to efficiently identify mTOR/TOR inhibitors with improved specificity and sensitivity. The platform not only accelerates the discovery of geroprotective and anticancer candidates but also rigorously validates compound specificity, as demonstrated by the non-inhibition of TOR by Nebivolol hydrochloride.

• Refining In Vitro Drug Response Evaluation in Cancer Researc

  2026-05-25

  Schwartz's dissertation advances in vitro cancer drug assessment by dissecting the relationship between growth inhibition and cell death using dual viability metrics. This approach clarifies the mechanisms of action for compounds such as Wee1 kinase inhibitors and supports more precise translational research strategies.

• CD163+ Macrophages Drive Granulosa Cell Apoptosis in PCOS

  2026-05-24

  This study demonstrates that increased activation and expression of CD163 in ovarian macrophages promote granulosa cell apoptosis, elucidating a key inflammatory mechanism in polycystic ovary syndrome (PCOS) pathology. These findings clarify how immune cell–derived inflammation disrupts follicular development, offering new directions for targeted intervention in PCOS models.

• 2-D08 (2’,3’,4’-trihydroxyflavone): Redefining SUMOylation I

  2026-05-23

  Explore how 2-D08 (2’,3’,4’-trihydroxyflavone) uniquely enables selective sumoylation inhibition for advanced cellular and disease modeling. This article provides an in-depth analysis of its mechanistic innovation and practical implications for posttranslational modification studies.

• 1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine: Elevating Rese

  2026-05-22

  PP 3, as a rigorously validated negative control, empowers researchers to pinpoint Src kinase-specific effects in cell signaling pathway studies. Discover stepwise protocols, troubleshooting wisdom, and new insights from vascular ROS research, ensuring your kinase inhibitor assays are both specific and reproducible.

• Thrombin B Chain Fragment: Applied Workflows, Troubleshootin

  2026-05-22

  Unlock the full experimental potential of the Thrombin B Chain Fragment in coagulation, fibrin matrix modeling, and vascular research. This guide delivers hands-on protocol parameters, troubleshooting essentials, and actionable insights drawn from recent mechanistic studies—clarifying how APExBIO’s high-purity product drives reproducible results.

• BMN 673 (Talazoparib): Redefining PARP Inhibition Strategy

  2026-05-21

  Explore how BMN 673 (Talazoparib) advances targeted cancer research by integrating the latest mechanistic insights into PARP1/2 inhibition and BRCA2-RAD51 dynamics. This article offers a unique, assay-focused perspective for researchers in homologous recombination deficient cancer treatment.

• Recombinant Mouse Sonic Hedgehog: Optimizing SHH Protein Wor

  2026-05-21

  Recombinant Mouse Sonic Hedgehog (SHH) protein empowers precise modeling of developmental signaling, delivering reliable activity for limb, brain, and urogenital patterning studies. This guide details protocol optimization, troubleshooting, and practical innovations grounded in comparative developmental biology.

• Mechanisms of Cell Death in Liver Disease: Clinical Implicat

  2026-05-20

  This review elucidates the molecular pathways underpinning cell death in liver disease and their clinical relevance. It highlights how different modes of hepatocyte death—apoptosis, necrosis, and necroptosis—drive liver pathology, influencing progression to fibrosis, cirrhosis, and hepatocellular carcinoma, and underscores the importance of targeting these pathways in research and therapy.

• Metronidazole (SKU B1976): Reliable OAT3 Inhibition in Lab A

  2026-05-20

  This article provides evidence-based guidance for biomedical researchers using Metronidazole (SKU B1976) in cell viability, cytotoxicity, and transporter assays. Scenario-driven Q&A blocks address reproducibility, protocol optimization, and vendor reliability, highlighting how high-purity Metronidazole from APExBIO delivers confidence in experimental results.

• Targeting AR and ARv7 in TNBC: Insights from EPI-001 Inhibit

  2026-05-19

  This study demonstrates that androgen receptor (AR) and its splice variant ARv7 are indicators of poor prognosis in triple-negative breast cancer (TNBC), with high expression linked to increased metastasis and reduced survival. The research provides mechanistic evidence that targeting AR/ARv7—particularly using the N-terminal domain inhibitor EPI-001—modulates metastasis and EMT pathways in vitro, offering new directions for therapeutic research.

• Faropenem Sodium: Penem Antibiotic Workflows for Resistance

  2026-05-19

  Faropenem sodium stands out as a versatile penem antibiotic for advanced bacterial inhibition studies, offering unique oral bioavailability and exceptional activity against anaerobes. This article delivers actionable protocol guidance, troubleshooting strategies, and a translational perspective for leveraging Faropenem sodium in antimicrobial resistance and infection model research.

• Moxidectin Boosts Polyene Efficacy Against Oral Candida via

  2026-05-18

  This study reveals that moxidectin, a macrocyclic lactone anthelmintic, increases ergosterol biosynthesis in Candida albicans, thereby amplifying the antifungal effects of polyenes such as amphotericin B and nystatin. These findings suggest a promising strategy to overcome clinical limitations of polyene therapy for oral candidiasis.

454 records 17/31 page Previous Next First page 上5页 1617181920 下5页 Last page